Wo liegen die Grenzen der Wissenschaft? – Hundertprozentige Eradikation der Erreger bei Onychomykosen? Wunsch und Wirklichkeit

Dr. Dieter Reinel

Kommentar zu Iorizzo M, Hartmane I, Derveniece A, Mikazans I. Ciclopirox 8 % HPCH Nail Lacquer in the Treatment of Mild-to-Moderate Onychomycosis: A Randomized, Double-Blind Amorolfine Controlled Study Using a Blinded Evaluator. Skin Appendage Disord 2016; 1: 134 – 140 [1]

• Literatur

• 1 Iorizzo M, Hartmane I, Derveniece A. et al. Ciclopirox 8 % HPCH Nail Lacquer in the Treatment of Mild-to-Moderate Onychomycosis: A Randomized, Double-Blind Amorolfine Controlled Study Using a Blinded Evaluator. Skin Appendage Discord 2016; 1: 134-140
• 2 Lipner SR. Pharmacotherapy for onychomycosis: new and emerging treatments. Expert Opin Pharmacother 2019; 28: 1-11
• 3 Iorizzo M, Hartmane I, Derveniece A. et al. Erratum. Ciclopirox 8 % HPCH Nail Lacquer in the Treatment of Mild-to-Moderate Onychomycosis: A Randomized, Double-Blind Amorolfine Controlled Study Using a Blinded Evaluator. Skin Appendage Discord 2016; 1: 168 doi:10.1159/000443912
• 4 Pub Med Central. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857848/ Zugriff am 21. 3. 2019
• 5 Baran R, Tosti A, Hartmane I. et al. . An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol 2009; 23: 773-781